Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496574
Status:
UNKNOWN
Last Update Posted:
2013-02-07
First Post:
2007-07-03
Brief Title:
Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma
Sponsor:
Medical University of Lodz
Organization:
Medical University of Lodz
Study Overview
Official Title:
Evaluation of Long-term Clinical Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma
Status:
UNKNOWN
Status Verified Date:
2013-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to assess the effect of specific immunotherapy SIT to dust mites on clinical symptoms reliever drugs usage inhaled glucocorticosteroid usage quality of life lung function bronchial hyperreactivity with methacholine and presence and type of allergy after three years of SIT in children with asthma
Detailed Description:
According to Global Initiative for Asthma treatment of asthma is based on avoidance of allergens pharmacological treatment and specific immunotherapy
The aim of the study is to assess the effect of specific immunotherapy SIT to dust mites on clinical symptoms reliever drugs usage inhaled glucocorticosteroid usage quality of life lung function bronchial hyperreactivity with methacholine and presence and type of allergy after three years of SIT in children with asthma
The aim of the study is to assess the effect of specific immunotherapy SIT to dust mites on clinical symptoms reliever drugs usage inhaled glucocorticosteroid usage quality of life lung function bronchial hyperreactivity with methacholine and presence and type of allergy after three years of SIT in children with asthma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None